Landazabal (Gsk): “Speed up access to innovation”

Posted on November 24, 2021 by Design in Design Innovation | 0 Comments

“Covid has shown how important the industry is”

All drug companies have been and are at the forefront of the world to make their contribution in the fight against Covid-19. There is also talk of Covid in San Polo di Torrile, at the Farmindustria conference, and given the maximum effort in recent months to ensure that medicines are not lacking, it could not be otherwise. Some companies have modified their production lines to meet health needs and in particular to meet the growing demand for disinfectant products, which are sold free of charge to the Civil Protection.

Today there are over 320 vaccines in development worldwide, of which 130 are in clinical trials, with 4 authorizations for placing on the market in Europe. Which could be followed shortly by others, considering that there are 4 vaccines in rolling review by Ema. After more than 200 clinical trials and nearly 300 partnerships and collaborations between manufacturers from all over the world, the production is; increased in a few months from zero to 2.2 billion doses of the anti-Covid-19 vaccine by the end of May, and production is estimated to reach 12.6 billion doses by the end of the year (Airfinity data).

“The pandemic has demonstrated the importance of the pharmaceutical industry, for national security and for work & ndash; explained Fabio Landazabal, president and CEO of GSK – today we are in Gsk in a global site where we produce new drugs for many diseases not only for Italy but internationally. Without innovation, without research we can do nothing. This is our mission as Farmindustria, to develop new solutions for the new diseases. Covid is a problem now, but our goal is a healthy society. For this we need a policy in Italy where access to innovation is enhanced to introduce new drugs (especially those in emergency situations ) more quickly and in line with other countries and this could save millions of lives “.

The post Landazabal (Gsk): “Speed up access to innovation” appeared first on The Koztimes.